Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 2, 2013, Pages

  Farr, Joshua N ^a   Khosla, Sundeep ^a   Miyabara, Yuko ^d   Miller, Virginia M ^b,c   Kearns, Ann E ^a,e  

^a Division of Endocrinology   (United States)

^b Department of Surgery ^*  (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; BONE DENSITY; BONE FRAGILITY; BONE MASS; BONE STRENGTH; BONE STRUCTURE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; OSTEOLYSIS; OUTCOME ASSESSMENT; POROSITY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORACIC SPINE; TRABECULAR BONE; VOLUMETRY;

BONE DENSITY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PROGESTERONE; RADIUS;

EID: 84873676088     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3406     Document Type: Article

References (52)

1. Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis. JAMA. 1941;116:2465-2474.
2. Lindsay R, Aitken JM, Anderson JB, Hart DM, MacDonald EB, Clarke AC. Long-term prevention of postmenopausal osteoporosis by oestrogen: evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet. 1976;1:1038-1041.
3. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985; 102:319-324.
4. Genant HK, Cann CE, Ettinger B, Gordan GS. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med. 1982;97:699-705.
5. Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med. 1987;106:40-45.
6. Riggs BL, Khosla S, Melton LJ III. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res. 1998;13:763-773.
7. Khosla S, Melton LJ III, Riggs BL. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res. 2011;26:441-451.
8. Riggs BL, Wahner HW, Melton LJ III, Richelson LS, Judd HL, Offord KP. Rates of bone loss in the appendicular and axial skeletons of women: evidence of substantial vertebral bone loss before menopause. J Clin Invest. 1986;77:1487-1491.
9. Riggs BL, Melton LJ III, Robb RA, et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res. 2004;19: 1945-1954.
10. Riggs BL, Melton LJ, Robb RA, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res. 2008;23:205-214.
11. Harman SM, Brinton EA, Cedars M, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric. 2005;8:3-12.
12. Miller VM, Black DM, Brinton EA, et al. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res. 2009;2:228-239.
13. Khosla S, Riggs BL, Atkinson EJ, et al. Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res. 2006;21:124-131.
14. Laib A, Hildebrand T, Hauselmann HJ, Ruegsegger P. Ridge number density: a new parameter for in vivo bone structure analysis. Bone. 1997;21:541-546.
15. Laib A, Hauselmann HJ, Ruegsegger P. In vivo high resolution 3DQCT of the human forearm. Technol Health Care. 1998;6:329-337.
16. Laib A, Ruegsegger P. Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography. Bone. 1999;24:35-39.
17. Nicks KM, Amin S, Atkinson EJ, Riggs BL, Melton LJ III, Khosla S. Relationship of age to bone microstructure independent of areal bone mineral density. J Bone Miner Res. 2012;27:637-644.
18. Parfitt AM. Stereologic basis of bone histomorphometry: theory of quantitative microscopy and reconstruction of the third dimension. Boca Raton, FL: CRC Press; 1983.
19. Kazakia GJ, Hyun B, Burghardt AJ, et al. In vivo determination of bone structure in postmenopausal women: a comparison of HRpQCT and high-fieldMRimaging. J Bone Miner Res. 2008;23:463-474.
20. Buie HR, Campbell GM, Klinck RJ, MacNeil JA, Boyd SK. Automatic segmentation of cortical and trabecular compartments based on a dual threshold technique for in vivo micro-CT bone analysis. Bone. 2007;41:505-515.
21. Burghardt AJ, Buie HR, Laib A, Majumdar S, Boyd SK. Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT. Bone. 2010;47: 519-528.
22. Burghardt AJ, Kazakia GJ, Ramachandran S, Link TM, Majumdar S. Age- and gender related differences in the geometric properties and biomechanical significance of intra-cortical porosity in the distal radius and tibia. J Bone Miner Res. 2010;25:983-993.
23. Nishiyama KK, Macdonald HM, Buie HR, Hanley DA, Boyd SK. Postmenopausal women with osteopenia have higher cortical porosity and thinner cortices at the distal radius and tibia than women with normal aBMD: an in vivo HR-pQCT study. J Bone Miner Res. 2010;25:882-890.
24. Jayachandran M, Litwiller RD, Owen WG, et al. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol. 2008;295:H931-H938.
25. Miyabara Y, Camp J, Holmes D III, et al. Coronary arterial calcification and thoracic spine mineral density in early menopause. Climacteric. 2011;14:438-444.
26. Camp JJ, Karwoski RA, Stacy MC, et al. A system for the analysis of whole-bone strength from helical CT images. Proc SPIE. 2004; 5369:74-88.
27. Budoff MJ, Hamirani YS, Gao YL, et al. Measurement of thoracic bone mineral density with quantitative CT. Radiology. 2010;257: 434-440.
28. Prevrhal S, Fox JC, Shepherd JA, Genant HK. Accuracy of CT-based thickness measurement of thin structures: modeling of limited spatial resolution in all three dimensions. Med Phys. 2003;30:1-8.
29. Stevenson JC, Cust MP, Gangar KF, Hillard TC, Lees B, Whitehead MI. Effect of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet. 1990;336:265-269.
30. Hillard TC, Whitcroft SJ, Marsh MS, et al. Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss. Osteoporos Int. 1994;4:341-348.
31. Miller VM, Clarkson TB, Harman SM, et al. Women, hormones, and clinical trials: a beginning, not an end. J Appl Physiol. 2005; 99:381-383.
32. Seeman E, Delmas PD. Bone quality-the material and structural basis of bone strength and fragility. NEngl J Med. 2006;354:2250-2261.
33. Bonnick SL. Skeletal anatomy in densitometry. In: Bonnick SL, ed. Bone Densitometry in Clinical Practice. New York, NY: Humana Press; 1998;35-78.
34. Rockoff SD, Sweet E, Bleustein J. The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae. Calcif Tissue Res. 1969;3:163-175.
35. Boutroy S, Van Rietbergen B, Sornay-Rendu E, Munoz F, Bouxsein ML, Delmas P. Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Miner Res. 2008;23:392-399.
36. Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int. 2001;12:989-995.
37. Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LJ III. Differential changes in bone mineral density of the appendicular skeleton with aging: relationship to spinal osteoporosis. J Clin Invest. 1981;67:328-335.
38. Han ZH, Palnitkar D, Rao S, Nelson D, Parfitt AM. Effect of ethnicity and age or menopause on the structure and geometry of iliac bone. J Bone Miner Res. 1996;11:1967-1975.
39. Yeni YN, Brown CU, Wang Z, Norman TL. The influence of bone morphology on fracture toughness of the human femur and tibia. Bone. 1997;21:453-459.
40. Diab T, Vashishth D. Effects of damage morphology on cortical bone fragility. Bone. 2005;37:96-102.
41. Genant HK, Boyd D. Quantitative bone mineral analysis using dual energy computed tomography. Invest Radiol. 1977;12:545-551.
42. Syed FA, Oursler MJ, Hefferanm TE, Peterson JM, Riggs BL, Khosla S. Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int. 2008;19:1323-1330.
43. Kricun ME. Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol. 1985;14:10-19.
44. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 1996;11:1043-1051.
45. Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23:279-302.
46. Rogers A, Eastell R. The effect of 17β-estradiol on production of cytokines in cultures of peripheral blood. Bone. 2001;29:30-34.
47. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. 2003;290:1729-1738.
48. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
49. Khosla S. Update on estrogens and the skeleton. J Clin Endocrinol Metab. 2010;95:3569-3577.
50. Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA. 2002;287:2668-2676.
51. Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M. Ultralowdose micronized 17β-estradiol and bone density and bone metabolism in older women: a randomized controlled trial. JAMA. 2003; 290:1042-1048.
52. Huang AJ, Ettinger B, Vittinghoff E, Ensrud KE, Johnson KC, Cummings SR. Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women. J Bone Miner Res. 2007;22: 1791-1797.